North Caldwell, NJ, United States of America

David J Blythin




Average Co-Inventor Count = 2.0

ph-index = 12

Forward Citations = 430(Granted Patents)


Location History:

  • Caldwell, NJ (US) (1981)
  • West Caldwell, NJ (US) (1983)
  • N. Caldwell, NJ (US) (1987)
  • North Caldwell, both, NJ (US) (1991)
  • North Caldwell, NJ (US) (1981 - 2011)

Company Filing History:


Years Active: 1981-2011

Loading Chart...
Loading Chart...
Loading Chart...
41 patents (USPTO):

Title: The Innovation Journey of David J Blythin: Revolutionizing Pharmaceuticals

Introduction

David J Blythin, a prolific inventor based in North Caldwell, NJ, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 41 patents. His relentless pursuit of innovation and commitment to excellence have cemented his reputation as a trailblazer in the industry.

Latest Patents

Among his latest patents is the groundbreaking discovery of maleate, tosylate, fumarate, and oxalate salts of the compound 5-(1(S)-Amino-2-Hydroxyethyl)-N-[(2,4-Difluorophenyl)-Methyl]-2-[8-Methoxy-2-(Trifluoromethyl)-5-Quinoline]-4-Oxazolecarboxamide. This compound, represented by Formula I, showcases his expertise in drug development and preparation processes. Furthermore, his innovation in substituted 2-quinolyl-oxazoles as potent PDE4 inhibitors highlights his dedication to advancing pharmaceutical research.

Career Highlights

David J Blythin is associated with the Schering Corporation, a renowned pharmaceutical company known for its cutting-edge research and development initiatives. His role at Schering Corporation underscores his involvement in high-impact projects aimed at transforming the healthcare landscape through innovative drug discoveries.

Collaborations

In his professional journey, Blythin has collaborated with esteemed colleagues such as Ho-Jane Shue and Xiao Chen. These collaborations have not only enriched his work but also led to the creation of groundbreaking solutions that have the potential to revolutionize the pharmaceutical industry.

Conclusion

In conclusion, David J Blythin's exemplary contributions to the field of pharmaceuticals epitomize the essence of innovation and ingenuity. His passion for pushing boundaries, coupled with his collaborations and groundbreaking patents, underscores his status as a visionary inventor. As he continues to make strides in pharmaceutical research, Blythin remains a driving force behind the creation of transformative healthcare solutions that have the potential to shape the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…